CDK4 and breast carcinoma: Random forest was also used to predict CDK4/6 inhibitor and endocrine therapy efficacy based on bacterial species in faecal microbiome of metastatic breast cancer patients54, and to characterise endocrine therapy resistance to identify pre-adapted breast cancer cells based on differently expressed biomarkers55.